Economist30 Nov 2019 18:45
My subscription Economist arrived today, 30th November.
There is a very interesting article about Novartis, & the boss, Vas Narasimhan going on a buying spree.
He snapped up an eye drug from Takeda for $5.3bn,
Endocyte, a small biopharma firm for $2.1bn
& EveXis, a gene therapy firm for $8.7bn.
Mr Narasimhan says he is focussing on ‘Transformative Innovation’.
If there was ever a phrase that described Nuformix that one leapt out of the article at me.
I’m seriously starting to think an MCap of $1 Billion may well be aiming a tad low.
(We could well have 3 blockbuster drugs out of the blocks and the technology to create a number more, in quick succession- Cocrystal Technology - Transformative Innovation indeed!!)